1. Home
  2. OFRM vs CERT Comparison

OFRM vs CERT Comparison

Compare OFRM & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OFRM

Once Upon a Farm PBC

N/A

Current Price

$19.38

Market Cap

684.3M

Sector

N/A

ML Signal

N/A

CERT

Certara Inc.

HOLD

Current Price

$5.54

Market Cap

808.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFRM
CERT
Founded
2015
2008
Country
United States
United States
Employees
153
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
684.3M
808.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
OFRM
CERT
Price
$19.38
$5.54
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$27.75
$11.67
AVG Volume (30 Days)
394.8K
4.1M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
$29.42
$4.18
Revenue Next Year
$34.69
$5.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.75
52 Week Low
$14.00
$4.45
52 Week High
$27.00
$13.88

Technical Indicators

Market Signals
Indicator
OFRM
CERT
Relative Strength Index (RSI) 66.13 50.61
Support Level $14.35 $5.08
Resistance Level $24.37 $6.37
Average True Range (ATR) 1.04 0.37
MACD 0.41 0.06
Stochastic Oscillator 82.91 44.92

Price Performance

Historical Comparison
OFRM
CERT

About OFRM Once Upon a Farm PBC

Once Upon a Farm PBC is a provider of baby food products. The company provides childhood nutrition with real, organic, farm-fresh food-made with no added sugar, no preservatives, and nothing artificial. Its products are available at retail customers, including Target, Whole Foods, Kroger, Walmart, Publix, and Wegmans. Its key products include Smoothies, Yogurt, Milk Shakes, Oat Bars, etc.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: